TERN.D

Terns Pharmaceuticals, Inc.

Sector not classified

$207.71 sample

-1.99 (-0.95%) 1D

Market cap

$155.3B

Price as of

2026-10-24

Latest filing

8-K · 2026-09-17

Alerts

8

Price$207.71 +9.80% 3M daily closessample

214.11189.17

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20INSInsider sell: General Counsel
Oct 14INSInsider sell: Director
Oct 08INSInsider sell: 10% owner
Sep 30INSInsider buy: Chief Financial Officer
Sep 23INSInsider sell: 10% owner
Sep 17SEC10-Q filed
Sep 14SECForm 144 filed
Sep 03SECDEF 14A filed

Sign up to see the real TERN.D record →

Company facts

SEC EDGAR registration

Name: Terns Pharmaceuticals, Inc.
Sector: not classified
Industry: not classified
Smart-money score: -5sample, -100 to +100
Reporting currency: USD

Who is positioning in TERN.D

sample

Insiders: 6 insider transactions over 90 days, net selling, $785.4M
Congress: 4 members traded over 90 days
Institutions · 13F: 21 funds hold $1.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$3.6B +10.1% y/y

Q4 2024Q3 2026

Inventory$2.2B +13.5% y/y

Q4 2024Q3 2026

Accounts receivable$1.6B +13.8% y/y

Q4 2024Q3 2026

Total debt$4.2B +5.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $92.4B -5.5% 3M
Sample peer B: $94.7B -0.2% 3M
Sample peer C: $98.5B +13.4% 3M
Sample peer D: $91.0B +11.0% 3M
Sample peer E: $78.4B -6.7% 3M